MindSet Pharma Says Its Psilocybin Formula Is the ‘Perfect Microdosing Drug’
“The potential market for microdosing could be absolutely enormous because it is easier, more convenient, and more familiar,” says Mindset Pharma CEO James Lanthier.
“The potential market for microdosing could be absolutely enormous because it is easier, more convenient, and more familiar,” says Mindset Pharma CEO James Lanthier.
This isn’t the first time the hit songwriter has turned to psychedelics for therapy, either.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.